Value Sense
NTCO
Natura &Co Holding S.A. (NTCO)
Last Price$7.00.0%
Market Cap$9,645.8M
LTM Capital Expenditure
($103.8M)
YoY Growth
-51.0%
3Y CAGR
-20.1%
5Y CAGR
-7.2%
Stock quality & Intrinsic value
5/10
54.0% overvalued
NTCO
is (54.0%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Natura &Co Holding S.A. Capital Expenditure

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Capital Expenditure
($224.5M)
($257.4M)
($215.2M)
($116.6M)
($88.1M)
($114.0M)
($133.4M)
($148.6M)
($131.9M)
($273.9M)
($213.5M)
($189.3M)
NTCO
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NTCO and see if it's the right time to invest.
Dive in

Natura &Co Holding S.A. (NTCO) Capital Expenditure comparison analysis

General

LTM Capital Expenditure

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Natura &Co Holding S.A. logo
Natura &Co Holding S.A.NTCO
($103.8M)
(51.0%)
(20.9%)
(1.5%)
Median Peer Set
($497.5M)
(2.3%)
4.0%
(0.1%)
Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
($52.8M)
99.1%
119.2%
147.0%
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
($179.8M)
(19.6%)
14.8%
19.5%
The Clorox Company logo
The Clorox CompanyCLX
($228.0M)
5.6%
(7.6%)
(0.3%)
Coty Inc. logo
Coty Inc.COTY
($244.9M)
1.3%
18.2%
(4.7%)
Kenvue Inc. logo
Kenvue Inc.KVUE
($434.0M)
(7.5%)
52.2%
N/A
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
($561.0M)
(20.4%)
(0.4%)
10.9%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
($665.0M)
(80.4%)
(7.7%)
(2.2%)
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
($721.0M)
(5.9%)
(10.5%)
(9.8%)
Unilever PLC logo
Unilever PLCUL
($3,429.3M)
26.9%
3.8%
(3.0%)
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
($3,498.0M)
9.1%
4.3%
1.5%

NTCO key stats

USD
BRL
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
3,256.1
0.0%
3,257.7
0.1%
3,151.9
(3.2%)
2,405.6
(23.7%)
2,278.7
(5.3%)
3,082.1
35.3%
3,683.8
19.5%
3,661.4
(0.6%)
7,221.0
97.2%
7,438.1
3.0%
7,036.5
(5.4%)
5,344.0
(24.1%)
Cost of Goods Sold (COGS)958.5981.0957.3784.6757.5910.61,040.11,022.42,587.42,594.82,546.51,933.8
Gross Profit
% margin
2,297.5
70.6%
2,276.7
69.9%
2,194.6
69.6%
1,621.1
67.4%
1,521.2
66.8%
2,171.5
70.5%
2,643.7
71.8%
2,639.0
72.1%
4,633.6
64.2%
4,843.3
65.1%
4,489.9
63.8%
3,410.2
63.8%
Operating Expenses1,610.61,679.11,710.31,258.41,229.01,642.52,206.02,295.84,336.94,385.84,500.03,441.1
Research & Development Expenses (R&D)81.585.192.863.622.125.028.222.752.941.452.932.3
Selling, General & Administrative Expenses (SG&A)1,588.21,620.81,622.41,258.41,225.01,720.82,140.72,230.94,235.94,185.94,349.02,883.9
Operating Income
% margin
702.0
21.6%
653.7
20.1%
578.7
18.4%
362.7
15.1%
292.2
12.8%
425.0
13.8%
345.5
9.4%
838.7
22.9%
691.7
9.6%
428.6
5.8%
(5.5)
(0.1%)
(30.9)
(0.6%)
Interest Income20.813.117.915.218.351.435.6495.8926.749.0104.00.0
Interest Expense0.00.00.00.00.0121.3173.6708.71,129.2158.6144.1300.2
Pre-tax Income666.2584.5466.5266.6122.9303.8185.277.2(48.1)16.9(456.6)(533.3)
Income Tax
% effective tax rate
217.5
32.7%
190.5
32.6%
151.1
32.4%
107.4
40.3%
34.2
27.8%
94.1
31.0%
34.4
18.6%
37.8
48.9%
53.7
(111.8%)
(194.1)
(1,148.4%)
23.2
(5.1%)
(17.3)
3.2%
Net Income
% margin
448.7
13.8%
391.6
12.0%
311.8
9.9%
156.4
6.5%
85.4
3.7%
209.7
6.8%
150.8
4.1%
39.4
1.1%
(101.8)
(1.4%)
194.1
2.6%
(479.7)
(6.8%)
(664.1)
(12.4%)
EPS21.2518.6714.837.494.019.887.221.87(3.37)5.77(14.37)17.70
Diluted EPS21.2518.6714.837.494.019.887.101.87(3.37)5.69(14.37)17.62
EBITDA
% margin
873.4
26.8%
720.0
22.1%
652.2
20.7%
471.2
19.6%
301.9
13.2%
569.6
18.5%
535.7
14.5%
544.5
14.9%
819.1
11.3%
765.8
10.3%
113.7
1.6%
84.2
1.6%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Natura &Co Holding S.A.'s Capital Expenditure?

As of today, Natura &Co Holding S.A.'s last 12-month Capital Expenditure is ($103.8M), based on the financial report for Sep 30, 2024 (Q3’2024).

2) What is Natura &Co Holding S.A.'s Capital Expenditure growth rate?

Over the last year, Natura &Co Holding S.A.'s Capital Expenditure growth was (51.0%). The average annual Capital Expenditure growth rates for Natura &Co Holding S.A. have been (12.3%) over the past three years, (7.2%) over the past five years.

3) Is Natura &Co Holding S.A.'s Capital Expenditure growth rate Good?

Over the last year, Natura &Co Holding S.A.'s Capital Expenditure growth was (51.0%), which is lower than industry growth of (0.2%). It indicates that Natura &Co Holding S.A.'s Capital Expenditure growth is Good.

4) How does Natura &Co Holding S.A.'s Capital Expenditure growth rate compare to its peers?

Over the last year, Natura &Co Holding S.A.'s Capital Expenditure growth was (51.0%), which is lower than peer median growth of (15.2%). The list of peers includes HIMS, CHD, CLX, COTY, KVUE, CL, EL, KMB, UL, PG etc.